Canon Medical Systems USA Presents Its First-Ever U.S. Mobile Truck Tour with the Launch of Canon Across America

A Mobile Roadshow Designed to Showcase the Future of Medical Imaging

Canon Medical Systems USA, Inc. (CMSU), a global leader in innovative diagnostic imaging technology, is proud to announce its first-ever U.S. mobile tour, Canon Across America, March 24th through December 2, 2022.

Canon Medical Systems USA will bring its state-of-the-art AI medical devices to hospitals and local healthcare providers in a unique hands-on experience to create stronger community engagement throughout the year.

CMSU’s 50-city mobile tour kicks off in its Tustin, CA headquarters and will travel across the country. The Canon Across America mobile truck tour aims to provide healthcare professionals and hospitals across the U.S. the opportunity to connect with Canon’s innovative solution-focused portfolios at a hands-on level by providing a holistic 360-degree view of their solutions. In addition, Canon will provide live demos, supportive conversations with Canon’s industry experts, and an opportunity to experience the benefits Canon’s platforms offer at their convenience.

“Providing in-person experiences with current and new customers is key for us as a company. It’s a vital opportunity to connect, ask pressing questions in a face-to-face setting, and to learn more about better servicing their needs,” said David Hashimoto, Vice President of Marketing and Sales Strategy. “We’re allowing unprecedented access to our technologies to better guide healthcare professionals with the essential information needed to make important decisions about their patients and business.”

Yuji Hamada, President and CEO of Canon Medical Systems USA, agrees. “Canon’s 50-city tour is a unique opportunity for healthcare professionals to gain access to personalized demos. The next generation of medical imaging allows us to provide our customers flexible visits with Canon’s reps and to focus on key areas of interest important to them. We look forward to this year-long journey of meeting our customers, friends, and colleagues and showcasing the very best that Canon has to offer.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.